Animal & Veterinary
SUPPLEMENTAL ABBREVIATED NEW ANIMAL DRUG APPROVALS - July/August 1999
FDA Veterinarian Newsletter July/August 1999 Volume XIV, No IV
|Company||Generic & (Brand) Names||Indications||Routes/Remarks|
|Boehringer Ingelheim Vetmedica, Inc. (ANADA 200-008)||Oxytetracycline (OxytetTM 200) (Bio-Mycin® 200)||Cattle, swine. In beef and nonlactating dairy cattle for treatment of bacterial pneumonia, shipping fever, pinkeye, foot rot, diphtheria, bacterial enteritis, wooden tongue, leptospirosis, wound infections, acute metritis. In swine for treatment of bacterial enteritis.||SUBCUTANEOUS AND INTRAMUSCULAR: The ANADA provides for a 28-day withdrawal period for subcutaneous use of oxytetracycline in cattle and for intramuscular use in swine.|
Federal Register: 05/17/99.